SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-063997
Filing Date
2015-02-26
Accepted
2015-02-26 07:06:08
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d835729d10k.htm 10-K 1487641
2 EX21.1 d835729dex211.htm EX-21.1 2309
3 EX-23.1 d835729dex231.htm EX-23.1 2263
4 EX-31.1 d835729dex311.htm EX-31.1 6695
5 EX-31.2 d835729dex312.htm EX-31.2 6678
6 EX-32.1 d835729dex321.htm EX-32.1 4231
7 EX-32.2 d835729dex322.htm EX-32.2 4235
14 GRAPHIC g835729g51n48.jpg GRAPHIC 84096
  Complete submission text file 0001193125-15-063997.txt   10560412

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT srpt-20141231.xml EX-101.INS 1603112
9 XBRL TAXONOMY EXTENSION SCHEMA srpt-20141231.xsd EX-101.SCH 78911
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20141231_cal.xml EX-101.CAL 91853
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20141231_def.xml EX-101.DEF 250723
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20141231_lab.xml EX-101.LAB 615476
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20141231_pre.xml EX-101.PRE 454895
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14895 | Film No.: 15650109
SIC: 2834 Pharmaceutical Preparations